What the business is, and whether it's a good one at a fair price.
Operates two reported segments on BSE — a small Healthcare (biotech/nutrition) business and rental income from a leasehold land holding — and is classified under Commodity Chemicals. In FY26, revenue from operations (the Healthcare segment) fell about 39% year-on-year to ₹37.08 lakh from ₹61.09 lakh, while total income of ₹240.66 lakh was supported by ₹165.31 lakh of rent on leasehold land booked as other income. Segment data for the year ending March 2026 shows Healthcare at ₹0.0928 crore, Rent on Leasehold Land at ₹0.4133 crore and Others at ₹0.0601 crore of period segment revenue. Profit after tax nevertheless rose 37.8% to ₹43.59 lakh (from ₹31.62 lakh) largely because the tax expense dropped from ₹64.20 lakh to ₹14.37 lakh. The company carries no debt and holds total assets of ₹9.5301 crore; employee cost of ₹1.0791 crore is several times its revenue from operations, indicating the core biotech activity is a very small contributor relative to fixed costs.
Measured from the filed financials, judged against its Commodity Chemicals peers — not investment advice
Not enough history to assess.How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from EMMESSAR BIOTECH & NUTRITION L's filed financials and exchange disclosures
EMMESSAR BIOTECH & NUTRITION L is a Chemicals & Petrochemicals company listed on BSE.
On trailing P/E, EMMESSAR BIOTECH & NUTRITION L ranks 55 of 57 in Commodity Chemicals — cheaper than 4% of them, against an industry median of 17.0×. This is a position, not a valuation judgement.
On a typical session EMMESSAR BIOTECH & NUTRITION L moves 2.18% — that is the median absolute close-to-close move across its last 266 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by EMMESSAR BIOTECH & NUTRITION L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
